Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.

Cooke, S L; Temple, J; Macarthur, S; Zahra, M A; Tan, L T; Crawford, R A F; Ng, C K Y; Jimenez-Linan, M; Sala, E; Brenton, J D

Cooke, S L; Temple, J; Macarthur, S; Zahra, M A; Tan, L T; Crawford, R A F; Ng, C K Y; Jimenez-Linan, M; Sala, E; Brenton, J D.

Affiliation

Cooke SL; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB20RE, UK.

Br J Cancer ; 104(2): 361-8, 2011 Jan 18.

Article in En | MEDLINE | ID: mdl-21063398

Subject(s)

Antineoplastic Agents/therapeutic use; Genetic Heterogeneity; Uterine Cervical Neoplasms/genetics; Adult; Aged; Combined Modality Therapy; Female; Humans; Middle Aged; Uterine Cervical Neoplasms/drug therapy; Uterine Cervical Neoplasms/radiotherapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Genetic Heterogeneity / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2011 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google